Page results
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
Patient information on managing pain
-
This page explains what an intra-oral scanner is and what it is used for.
-
Information about staff who work in the Macmillan Support and Information Service.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
File results
-
FOI/2023/0286 - Maternity services budget for 2018/19-2022/23
-
FOI/2023/0288 - Cancer treatment capacity
-
FOI/2023/0290 - Specialist palliative care units within the Trust
-
FOI/2023/0294 - Patient entertainment
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer